Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer

Cell Reports(2023)10.1016/j.celrep.2023.112016Source: DataRank Database

RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.43)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

H. Josh Jang ORCID,Krizia Rohena-Rivera ORCID,Minmin Liu ORCID,Hemant Gujar ORCID,Justin R. Kulchycki ORCID

Live enrichment

PubMed:36662621 PMC:PMC10034851 OpenAlex:https://openalex.org/W4317486140

National Cancer Institute

Grant: P30 CA014089

National Cancer Institute

Grant: R35 CA209859

National Cancer Institute

Grant: R50CA243878

National Institutes of Health

Grant: 1R50CA243878-01

Research Specialist Support-Targeting DNA Methylation and the Cancer Epigenome

National Institutes of Health

Grant: 3P30CA014089-17S1

USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT

National Institutes of Health

Grant: 5R35CA209859-05

Targeting DNA Methylation and the Cancer Epigenome

Cedars-Sinai Medical Center

U.S. Department of Veterans Affairs

National Institutes of Health

FWCI

2.43

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S221112472300027X/pdf

publisherhttp://www.cell.com/article/S221112472300027X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S221112472300027X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S221112472300027X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2023.112016

Fields of Study

RNA modifications and cancerEpigenetics and DNA MethylationRenal and related cancers0301 basic medicine0303 health sciences03 medical and health sciencesHumansHistonesKidney NeoplasmsCarcinoma, Renal CellChromatinRNA

MeSH Terms

Carcinoma, Renal CellChromatinHistonesHumansKidney NeoplasmsRNA

Keywords

EpigenomicsBiologyRNA splicingDNA methylationEpigeneticsHistoneCancer researchChromatinGeneticsRNAGeneGene expressionCcrccDnmt InhibitorsSetd2Viral MimicryRna Mis-splicingCp: CancerHistonesQH301-705.5HumansBiology (General)Carcinoma, Renal CellArticleKidney Neoplasms

Sustainable Development Goals

SDG 0: Good health and well-being

RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer

FAIR Checklist

Authors (14)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)